Evaluation of efficacy and safety of doxofylline 800mg sustained release tablet in treatment of patients with COPD: an open label, prospective and RCT

Background: COPD is a major cause of health care burden worldwide and leading cause of death that is increasing in prevalence. Methylxanthines are used in the treatment of patients with asthma and COPD. Doxofylline (methylxanthine) shows improved disease control, reduced total daily dose of inhaled...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of basic and clinical pharmacology 2018-04, Vol.7 (4), p.644
Hauptverfasser:	Khandelwal, Prakash Narayan, H. Maaz, Syed, Borade, Dhammraj M.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!